Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Consumer Discretionary · ·
$389.85
▲ $6.85 (+1.8%)
Market data updated: 09/19 09:24 AM
Fundamentals updated: 09/18/2026
News analyzed: 09/19/2026
Market Cap
$5.47B
Day Range
$382.54 - $390.00
52-Week Range
$240.24 - $805.75
Beta
—
Next Earnings
02.12.2026
Support
$377.15
Resistance
$681.04
AGX is a stock from the Consumer Cyclical sector — Retail, automotive, and leisure — demand rises and falls with economic sentiment and consumers' disposable income.
+50.2% (1Y)
Strengths: 11/28 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🔴 Bearish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
DCF Fair Value
Estimated fair value: $741.01 vs. price $389.85 (+90.1%)
Fair Value
Biggest negative driver
Daily volatility (ATR)
ATR: 6.8% of price
Risk
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
57
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
76
Quality
58
Value
57
Momentum
19
Risk
56
Sentiment
98
Fundamental
70
Institutional
0
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Argan, Inc. (AGX) has centered on its strong financial performance and strategic growth initiatives. The company reported record revenue ($384 million), net income ($53 million), and adjusted EBITDA ($70 million) in Q2 of fiscal 2027, prompting analyst upgrades from firms like Freedom Broker and Lake Street. Management highlighted its focus on mergers and acquisitions—such as the ValCor Communications deal—to expand into new markets like New England and access Fortune 500 clients in tech, defense, and aerospace. The positive earnings drove bullish sentiment and technical buying signals.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Argan, Inc.. News trend score: 98. Reason: 11 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
17
🎯 Conviction (vs. Emotion)
41
Psychology
62
Fundamentals
70
Technical
19
Valuation
57
A significant decline over time, but on unusually low trading volume — holders unwilling to accept the loss.
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price (3M)
-47%
Market Narrative
47
Fundamental Reality
41
Narrative Gap
+6
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior suggests a **conflicted but cautious stance**, with no single dominant bias. Elevated volume and extreme sentiment (100/100) could imply FOMO or euphoria, but weak momentum and undervaluation dampen those impulses. Loss aversion is the strongest signal, reflecting a defensive posture after a steep drawdown. The key tension lies between the narrative (optimistic sentiment) and reality (material undervaluation), with no clear catalyst to resolve this divergence. Traders may be holding positions despite weakness, waiting for confirmation of a bottom or reversal.
Updated: 09/09/2026, 03:07 AM
What could change this?
👥 What the crowd believes
"record revenue of $384 million, record net income of $53 million, and record adjusted EBITDA of $70 million"
"Lake Street upgrades Argan (AGX) to Buy from Hold and announces $600 price target"
"ongoing efforts to find acquisitions that complement its existing operations"
"RSI near 30, signaling oversold conditions and potential buying opportunities"
📈 13D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Samuel Armstrong Nelson — 95/100
🔴 Weakest match
Benjamin Graham (Enterprising Investor) — 24/100
🗣️ Why do they disagree?
This stock divides methodologies sharply, with some models seeing strong potential while others flag significant red flags. The highest-scoring approaches—like Samuel Armstrong Nelson’s cycle analysis (97) and Jack Schwager’s disciplined setup (88)—view it as a favorable opportunity, either because it’s near oversold or offers a high-reward/risk trade. Meanwhile, growth-focused investors like Peter Lynch (78) and Thorstein Veblen (71) see it as a promising long-term bet, assuming the price hasn’t yet reflected its true growth potential. However, value-oriented frameworks like Benjamin Graham’s (36) and Gerald Loeb’s (37) dismiss it outright, citing weak defensive metrics or excessive risk. Even moderate approaches, such as Howard Marks’ general assessment (69), acknowledge caution, while trend-following traders like Jesse Livermore (32) outright reject it for moving against their core strategy. The divide underscores whether the stock’s appeal lies in speculative momentum or structural growth versus traditional value or defensive investing.
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 95
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 83
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 80
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 80
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 80
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 72
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟢 71
Growth appears aligned with real value creation
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 69
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🟢 66
Solid, but not the exceptional quality Fisher looked for
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 51
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Walter Bagehot
Lombard Street (1873)
🟡 49
Adequate but not exceptional liquidity
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 45
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 45
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 37
Risk profile Loeb would flag as a real threat to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟡 36
Fails most of Graham's defensive criteria
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🔴 24
Not statistically cheap enough for the Enterprising Investor's looser safety bar
Key question
Is the stock statistically cheap enough to justify the extra risk?
Fact → Principle → Simulation
Based on the last 280 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (1 bullish · 10 bearish · 0 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear downtrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
20.5%
Operating Margin
14.3%
Net Margin
14.6%
EBITDA Margin
14.3%
ROE
29.8%
ROA
11.6%
ROIC
—
EPS
$10.00
Cash
$339.48M
Total Debt
—
Current Ratio
1.59
Debt/Equity
—
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 23.7.2026 | $0.500 |
| 22.7.2026 | $0.500 |
| 22.4.2026 | $0.500 |
| 21.4.2026 | $0.500 |
| 22.1.2026 | $0.500 |
| 21.1.2026 | $0.500 |
| 23.10.2025 | $0.500 |
| 22.10.2025 | $0.500 |
| 23.7.2025 | $0.375 |
| 22.7.2025 | $0.375 |
| 22.4.2025 | $0.375 |
| 21.4.2025 | $0.375 |
How is Fair Value calculated? →
Current Price
$389.85
Estimated Fair Value (DCF)
$741.01
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
+90.1%
🟢 Appears cheap relative to estimated value
Year 1 Growth Rate
25.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 25.0% | $513.55M | $471.15M |
| 2 | 19.4% | $613.05M | $515.99M |
| 3 | 13.8% | $697.35M | $538.48M |
| 4 | 8.1% | $754.01M | $534.16M |
| 5 | 2.5% | $772.86M | $502.30M |
Base FCF (last actual year)
$410.84M
Terminal Value
$12.19B
Present Value of Terminal Value
$7.92B
Enterprise Value
$10.48B
Net Debt
$0
Equity Value
$10.48B
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$32.68
Tangible Book Value per Share (Tangible NAV)
$30.59
Sentiment based on basic keywords (not AI) — 11 positive, 6 neutral, 3 negative out of the last 20 articles.
Zacks · 18.9.2026
Yahoo · 18.9.2026
Simply Wall St. · 18.9.2026
Yahoo · 18.9.2026
Zacks · 17.9.2026
Yahoo · 17.9.2026
Zacks · 16.9.2026
Yahoo · 16.9.2026
Barchart · 15.9.2026
Yahoo · 15.9.2026
Fintel · 15.9.2026
Zacks · 15.9.2026
Yahoo · 15.9.2026
Simply Wall St. · 15.9.2026
Yahoo · 15.9.2026
SeekingAlpha · 13.9.2026
Insider Monkey · 13.9.2026
Yahoo · 13.9.2026
Yahoo · 11.9.2026
Zacks · 11.9.2026
Argan, Inc. (AGX) currently has a StockIQ AI score of 57/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
AGX currently scores 57/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, AGX's estimated fair value is $741.01, which is 90.1% above the current price of $389.85. This is one valuation model among several signals in the fair-value category, not a price target.
AGX's technical score is 19/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Estimated fair value: $741.01 vs. price $389.85 (+90.1%); Earnings per share (EPS) growth: 58.4%; Free cash flow growth: 155.2%.
Based on the real signals StockIQ computed: ATR: 6.8% of price; Price is below the 50-day average; Price is below the 200-day average.
Yes — AGX has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 0 purchases and 13 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Collins Charles Edwin IV | Grant/Award from Employer | 9.9.2026 | 3,506 | +3,506 | — |
| Jeffrey John Ronald Jr. | Open Market Sale | 31.7.2026 | 5,716 | -5,716 | $579.64 |
| Jeffrey John Ronald Jr. | Open Market Sale | 31.7.2026 | 2,533 | -5,716 | $579.64 |
| Jeffrey John Ronald Jr. | Exercise of Derivative Securities | 30.6.2026 | 944 | +944 | $43.70 |
| Jeffrey John Ronald Jr. | Exercise of Derivative Securities | 30.6.2026 | 1,000 | -1,000 | $43.70 |
| Jeffrey John Ronald Jr. | Exercise of Derivative Securities | 30.6.2026 | 5,000 | -5,000 | $35.72 |
| Jeffrey John Ronald Jr. | Exercise of Derivative Securities | 30.6.2026 | 4,772 | +4,772 | $35.72 |
| Jeffrey John Ronald Jr. | Exercise of Derivative Securities | 30.6.2026 | 7,305 | +4,772 | $35.72 |
| Jeffrey John Ronald Jr. | Exercise of Derivative Securities | 30.6.2026 | 8,249 | +944 | $43.70 |
| Jeffrey John Ronald Jr. | Exercise of Derivative Securities | 30.6.2026 | 1,500 | -5,000 | $35.72 |
| Jeffrey John Ronald Jr. | Exercise of Derivative Securities | 30.6.2026 | 500 | -1,000 | $43.70 |
| Griffin William F Jr | Open Market Sale | 22.6.2026 | 20,000 | -20,000 | $760.43 |
| Griffin William F Jr | Open Market Sale | 22.6.2026 | 40,976 | -20,000 | $760.43 |
| Griffin William F Jr | Open Market Sale | 18.6.2026 | 30,000 | -30,000 | $725.85 |
| Griffin William F Jr | Open Market Sale | 18.6.2026 | 60,976 | -30,000 | $725.85 |
| Baugher Joshua Scott | Open Market Sale | 17.6.2026 | 305 | -305 | $734.00 |
| Getsinger Peter W | Open Market Sale | 17.6.2026 | 2,000 | -2,000 | $699.00 |
| Baugher Joshua Scott | Exercise of Derivative Securities | 17.6.2026 | 1,000 | -1,000 | $61.22 |
| Baugher Joshua Scott | Exercise of Derivative Securities | 17.6.2026 | 455 | +455 | $61.22 |
| Sweeney Karen | Open Market Sale | 17.6.2026 | 300 | -300 | $705.00 |
| Baugher Joshua Scott | Open Market Sale | 17.6.2026 | 455 | -455 | $732.83 |
| Getsinger Peter W | Open Market Sale | 17.6.2026 | 4,880 | -2,000 | $699.00 |
| Sweeney Karen | Open Market Sale | 17.6.2026 | 1,548 | -300 | $705.00 |
| Baugher Joshua Scott | Exercise of Derivative Securities | 17.6.2026 | 2,239 | +455 | $61.22 |
| Baugher Joshua Scott | Open Market Sale | 17.6.2026 | 1,784 | -455 | $732.83 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
1,069,740 shares short as of 2026-08-31 · vs. 1,040,824 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
42.8% of trading volume this week was short selling, vs. 65.8% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology